MRNA
Moderna Inc
Price:  
31.26 
USD
Volume:  
7,802,436.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

MRNA EV/EBITDA

-334.8%
Upside

As of 2025-07-19, the EV/EBITDA ratio of Moderna Inc (MRNA) is -3.42. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. MRNA's latest enterprise value is 10,525.74 mil USD. MRNA's TTM EBITDA according to its financial statements is -3,079.00 mil USD. Dividing these 2 quantities gives us the above MRNA EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 8.0x - 11.3x 9.6x
Forward P/E multiples 7.8x - 11.8x 9.9x
Fair Price (59.36) - (86.28) (73.41)
Upside -289.9% - -376.0% -334.8%
31.26 USD
Stock Price
(73.41) USD
Fair Price

MRNA EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-07-18 -3.42
2025-07-17 -3.54
2025-07-16 -3.52
2025-07-15 -3.46
2025-07-14 -3.62
2025-07-11 -3.72
2025-07-10 -3.80
2025-07-09 -3.61
2025-07-08 -3.58
2025-07-07 -3.25
2025-07-03 -3.32
2025-07-02 -3.30
2025-07-01 -3.10
2025-06-30 -2.96
2025-06-27 -2.90
2025-06-26 -2.95
2025-06-25 -2.87
2025-06-24 -2.86
2025-06-23 -2.72
2025-06-20 -2.75
2025-06-18 -2.68
2025-06-17 -2.70
2025-06-16 -2.76
2025-06-13 -2.84
2025-06-12 -2.93
2025-06-11 -2.98
2025-06-10 -2.97
2025-06-09 -3.03
2025-06-06 -2.94
2025-06-05 -2.77
2025-06-04 -2.92
2025-06-03 -2.99
2025-06-02 -2.89
2025-05-30 -2.83
2025-05-29 -2.87
2025-05-28 -2.76
2025-05-27 -2.85
2025-05-23 -2.79
2025-05-22 -2.85
2025-05-21 -2.73
2025-05-20 -3.01
2025-05-19 -2.81
2025-05-16 -2.61
2025-05-15 -2.46
2025-05-14 -2.51
2025-05-13 -2.69
2025-05-12 -2.72
2025-05-09 -2.54
2025-05-08 -2.55
2025-05-07 -2.51